Published in Cancer Causes Control on January 01, 1995
Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer (2001) 1.72
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis (2007) 1.66
Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther (2010) 1.45
Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol (2006) 1.43
Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol (2010) 1.35
Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA. J Rheumatol (2009) 1.04
Review: cancer-induced autoimmunity in the rheumatic diseases. Arthritis Rheumatol (2015) 0.94
Malignancies in Korean patients with inflammatory myopathy. Yonsei Med J (2006) 0.94
Lung cancer and interstitial lung diseases: a systematic review. Pulm Med (2012) 0.92
The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis. Rheumatol Int (2012) 0.87
Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in asian population. ISRN Rheumatol (2013) 0.86
Nasopharyngeal carcinoma in dermatomyositis patients: A 10-year retrospective review in Hospital Selayang, Malaysia. Rep Pract Oncol Radiother (2014) 0.86
Malignancy and idiopathic inflammatory myopathies. N Am J Med Sci (2013) 0.80
A mild form of dermatomyositis as a prodromal sign of lung adenocarcinoma: a case report. J Med Case Rep (2016) 0.80
Malignancy in dermatomyositis and polymyositis: analysis of 192 patients. Clin Rheumatol (2016) 0.79
Colon cancer presenting with polymyositis-A case report. Int J Surg Case Rep (2011) 0.76
Dermatomyositis masquerading as pulmonary embolism. Eur J Med Res (2009) 0.75
Dermatomyositis as a symptom of primary lung cancer: A case report and review of the literature. Oncol Lett (2016) 0.75
Red fist and muscle weakness with a rare complication. BMJ Case Rep (2014) 0.75
Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort. Rheumatol Int (2013) 0.75
Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review. Clin Rev Allergy Immunol (2017) 0.75
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull (1999) 14.29
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (2001) 6.23
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Prognosis of cancers associated with venous thromboembolism. N Engl J Med (2000) 4.51
The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med (1998) 4.41
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Induced abortion and the risk of breast cancer. N Engl J Med (1997) 4.04
Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94
Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol (1992) 3.80
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57
A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer (2000) 3.49
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med (1996) 3.18
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Selection of controls in case-control studies. III. Design options. Am J Epidemiol (1992) 2.88
Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst (1995) 2.83
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
The changing epidemiology of esophageal cancer. Semin Oncol (1999) 2.65
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Reliability of surrogate information on cigarette smoking by type of informant. Am J Epidemiol (1987) 2.49
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49
Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol (2001) 2.48
Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45
Rheumatoid arthritis and cancer risk. Eur J Cancer (1996) 2.44
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36
Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35
Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer (1994) 2.33
Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst (2000) 2.32
Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol (2001) 2.30
Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst (1969) 2.30
Declining lung cancer rates among young men and women in the United States: a cohort analysis. J Natl Cancer Inst (1989) 2.28
Cancer mortality among chemists. J Natl Cancer Inst (1969) 2.28
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res (1990) 2.21
Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med (1977) 2.20
Fluoridated drinking water and the occurrence of cancer. J Natl Cancer Inst (1976) 2.19
Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology (1998) 2.19
Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol (2000) 2.18
A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst (1984) 2.17
Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst (1998) 2.13
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12